NEW MEMBER SIGN UP
  Display Name
 
  Email Address
 
  Password
 
  Password again
 
  Zip
 
Country
 
   

Close Window

Privacy Statement
BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
     
Community Login

What is this?
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel Employers
 Post Job | Search Resumes | Login

NEWSLETTERS
Free Newsletters
Archive
My eNewsletters

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

COMMUNITY
Login
Become a Member
Discussion Forums
FAQ

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

BIOTECH WORK PORTAL
Career Definitions
Labor Market Reports
Education & Training
Regions

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Transition Therapeutics Inc. 

415 Yonge Street
Suite 1103
Toronto  Ontario  M5B2E7  Canada
Phone: 416-260-7770 Fax: 416-260-2886


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Transition Therapeutics Inc. (TTH.TO) Files Shelf Registration Statement 9/30/2009 9:02:32 AM    More...
Transition Therapeutics Inc. (TTH.TO) Announces Fiscal 2009 Year End Financial Results 9/17/2009 8:56:25 AM    More...
Transition Therapeutics Inc. (TTH.TO) to Hold Conference Call On Fiscal Year-End 2009 Financial Results On Wednesday, September 16th, At 4:30 P.M. EDT 9/15/2009 12:15:28 PM    More...
Transition Therapeutics Inc. (TTH.TO) to Present at Canaccord Adams 29th Annual Global Growth Conference 8/7/2009 10:33:54 AM    More...
Elan Corporation PLC (ELN) and Transition Therapeutics Inc. (TTH.TO) Announce Phase 1 Data Showing ELND005 Achieves Desired Concentrations in Brain Tissue and Cerebrospinal Fluid 7/13/2009 9:23:03 AM    More...
Transition Therapeutics Inc. (TTH.TO) Announces Appointment of Vice-President of Clinical Operations 6/19/2009 8:32:45 AM    More...
Transition Therapeutics Inc. (TTH.TO) Announces Third Quarter Fiscal 2009 Financial Results 5/14/2009 9:39:42 AM    More...
Transition Therapeutics Inc. (TTH.TO) to Hold Conference Call on Third Quarter Fiscal 2009 Financial Results on Wednesday, May 13th, at 4:30 P.M. EST 5/12/2009 8:41:16 AM    More...
Elan Corporation PLC (ELN) And Transition Therapeutics Inc. (TTH.TO) Receive Key Patent for Alzheimer’s Disease Treatment with ELND005 4/23/2009 9:16:52 AM    More...
Transition Therapeutics Inc. (TTH.TO) Announces Initiation of a Phase Ib Clinical Study of TT-223 in combination with a GLP-1 analogue in Patients with Type 2 Diabetes 3/23/2009 8:37:00 AM    More...
12345678